Mark A. Patterson

Heritage Pharmaceuticals, Inc. develops and markets pharmaceutical products. The firm also engages in the acquisition, development, marketing, licensing, sale, and distribution of generic pharmaceutical products for the prescription drug market in the United States. It offers tablets, capsules, and injections for a range of therapeutic categories, including cardiovascular, oncology, metabolic disease, anti-infective, infusion, and pain management. The company was founded in 2006 and is headquartered in East Brunswick, NJ.

JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.

Part of Wisepower Co., Ltd., C-Sixty, Inc. develops pharmaceutical products based on the fullerene molecule. The company is based in Houston, TX. The company was founded by Uri Sagman. C-Sixty was acquired by Carbon Nanotechnologies, Inc., a SUB of Wisepower Co., Ltd. from William Multi-Tech, Inc. on December 21, 2004.

Continental Lithium Ltd. engages in exploring, mining, trading, and exporting solid mineral. Its products include lithium spodumene, tin, columbite, zircon sand, monazite and tantalite. The company was founded by Lanre Afebuameh in 2017 and is headquartered in Jos South, Nigeria.